Home » Stocks » IGXT

IntelGenx Technologies Corporation (IGXT)

Stock Price: $0.2482 USD -0.0120 (-4.54%)
Updated Jan 20, 2021 3:59 PM EST - Market closed
Market Cap 27.59M
Revenue (ttm) 822,000
Net Income (ttm) -8.43M
Shares Out 110.26M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $0.2482
Previous Close $0.2600
Change ($) -0.0120
Change (%) -4.54%
Day's Open 0.2400
Day's Range 0.2400 - 0.2600
Day's Volume 104,294
52-Week Range 0.12 - 0.48

News

Hide News
  • All
  • Videos
  • Press Releases
GlobeNewsWire - 1 week ago

SAINT LAURENT, Quebec, Jan. 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (“IntelGenx” or the “Company”) today announced that its Board of Directors appoi...

GlobeNewsWire - 2 weeks ago

SAINT LAURENT, Quebec, Jan. 06, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Corporation” or “IntelGenx”) announced that on December 31, 2020, it issue...

GlobeNewsWire - 1 month ago

SAINT-LAURENT, Quebec, Dec. 08, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that it intends to issue 899,940 common...

GlobeNewsWire - 1 month ago

SAINT-LAURENT, Quebec, Nov. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTCQB:IGXT) announced today that the Company's board of dire...

Seeking Alpha - 2 months ago

IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Pa...

GlobeNewsWire - 2 months ago

- Data Suggest Montelukast May Inhibit Mental Decline , Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -

GlobeNewsWire - 2 months ago

SAINT LAURENT, Quebec, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results af...

GlobeNewsWire - 2 months ago

SAINT LAURENT, Quebec, Oct. 29, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has executed a binding letter of intent ...

GlobeNewsWire - 2 months ago

SAINT LAURENT, Quebec, Oct. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has closed a privat...

GlobeNewsWire - 3 months ago

SAINT LAURENT, Quebec, Oct. 21, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into an amended and restated...

GlobeNewsWire - 3 months ago

SAINT LAURENT, Quebec, Oct. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of pri...

GlobeNewsWire - 4 months ago

- Agreement Adds 26 Countries to Commercial Territory, with Initial Sales Expected in Early 2021-

GlobeNewsWire - 4 months ago

SAINT LAURENT, Quebec, Aug. 24, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTCQB:IGXT) announced today that the Company’s board of di...

Seeking Alpha - 5 months ago

Intelgenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 5 months ago

SAINT LAURENT, Quebec, Aug. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second q...

GlobeNewsWire - 5 months ago

SAINT LAURENT, Quebec, Aug. 06, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will r...

GlobeNewsWire - 6 months ago

SAINT LAURENT, Quebec, July 20, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it and Tilray, Inc. (“Tilray®”) have amen...

GlobeNewsWire - 6 months ago

SAINT LAURENT, Quebec, July 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) reported today, that the Company's Board of Di...

GlobeNewsWire - 6 months ago

SAINT LAURENT, Quebec, July 07, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, is pleased to announce that it has entered ...

GlobeNewsWire - 6 months ago

SAINT LAURENT, Quebec, June 25, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Corporation”) today announced that the holders (“Debenture...

GlobeNewsWire - 7 months ago

SAINT LAURENT, Quebec, June 11, 2020 (GLOBE NEWSWIRE) -- Saint Laurent, Quebec, June 11, 2020 – IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today provided an updat...

GlobeNewsWire - 7 months ago

First Purchase Order Received, with Product Availability Expected by early Q3-2020 First Purchase Order Received, with Product Availability Expected by early Q3-2020

GlobeNewsWire - 7 months ago

SAINT LAURENT, Quebec, June 08, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has...

Seeking Alpha - 8 months ago

Intelgenx Technologies Corp (IGXT) CEO Horst Zerbe on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

IntelGenx (IGXT) delivered earnings and revenue surprises of -50.00% and 102.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

IntelGenx (IGXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Benzinga - 9 months ago

Shares of Intelgenx Technologies (OTC:IGXT) remained unaffected at $0.26 after the company reported Q4 results.

Seeking Alpha - 1 year ago

IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

IntelGenx Corp. (IGXT) resubmits NDA for Rizaport VersaFilm for the treatment of acute migraines to the FDA.

About IGXT

IntelGenx Technologies, a drug delivery company, focuses on the development of novel oral thin film products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2008 for migraine; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat ... [Read more...]

Industry
Biotechnology
Founded
2003
CEO
Dr. Horst G. Zerbe
Employees
48
Stock Exchange
OTCMKTS
Ticker Symbol
IGXT
Full Company Profile

Financial Performance

In 2019, IGXT's revenue was $742,000, a decrease of -59.32% compared to the previous year's $1.82 million. Losses were -$10.66 million, 5.46% more than in 2018.

Financial Statements